BioCentury | Feb 25, 2021
Deals
Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen, AmacaThera, and more
...Co. and RA Capital Management and existing investors Atlas Venture, SV Health Investors, Takeda Ventures, RiverVest Venture Partners...